Attitudes of Patients with Cutaneous Melanoma Towards Prognostic Testing Using Gene Expression Profiling
Main Article Content
Keywords
Skin cancer
Abstract
N/A
References
prediction of distant metastasis (DM) in cutaneous melanoma (CM). J Clin Oncol.
2015;33(15_suppl):9066.
2. Ferris LK, Farberg AS, Middlebrook B, Johnson CE, Lassen N, Oelschlager KM, et al.
Identification of high-risk cutaneous melanoma tumors is improved when combining the
online American Joint Committee on Cancer Individualized Melanoma Patient Outcome
Prediction Tool with a 31-gene expression profile-based classification. J Am Acad
Dermatol. 2017 May;76(5):818-825.e3.
3. Dillon LD, Gadzia JE, Davidson RS, McPhee M, Covington KR, Cook RW, et al.
Prospective, Multicenter Clinical Impact Evaluation of a 31-Gene Expression Profile Test for
Management of Melanoma Patients. SKIN J Cutan Med. 2018 Mar;2(2):111–21.
4. Greenhaw BN. Estimation of Prognosis in Invasive Melanoma Using a Gene Expression
Profile Test. In 2016.
5. Keller J, Schwartz TL, Lizalek JM, Chang E, Patel AD, Hurley MY, et al. Prospective
validation of the prognostic 31‐gene expression profiling test in primary cutaneous
melanoma. Cancer Med. 2019 May;8(5):2205–12.
6. Podlipnik S, Carrera C, Boada A, Richarz NA, López-Estebaranz JL, Pinedo-Moraleda F, et
al. Early outcome of a 31-gene expression profile test in 86 AJCC stage IB-II melanoma
patients. A prospective multicentre cohort study. J Eur Acad Dermatol Venereol JEADV.
2019 May;33(5):857–62.
7. Hsueh EC, DeBloom JR, Lee JH, Sussman JJ, Covington KR, Caruso HG, et al. Long-Term
Outcomes in a Multicenter, Prospective Cohort Evaluating the Prognostic 31-Gene
Expression Profile for Cutaneous Melanoma. JCO Precis Oncol [Internet]. 2021 Apr 6
[cited 2021 Apr 6]; Available from: https://ascopubs.org/doi/pdf/10.1200/PO.20.00119
8. Brehaut JC, O’Connor AM, Wood TJ, Hack TF, Siminoff L, Gordon E, et al. Validation of a
Decision Regret Scale. Med Decis Making. 2003 Jul;23(4):281–92.
9. AM O. User Manual - Decision Regret Scale [Internet]. 1996 [cited 2020 Sep 29].
Available from:
https://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_Regret_Scale.pdf.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.